GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Codexis Inc.
Codexis is an engineering company that creates enzymes for the pharmaceutical and food industries. Its stock price reflects both revenue from existing partnerships and investor confidence in the potential of its platform to create new breakthrough products.
Share prices of companies in the market segment - Dna
Codexis, Inc. is a biotechnology company that develops enzymes for use in pharmaceuticals, food, and other industries. We've classified it as a "DNA" company because its work is based on protein engineering. The chart below shows the dynamics of the industrial biotechnology sector.
Broad Market Index - GURU.Markets
Codexis is a biotech company that develops enzymes for use in pharmaceuticals, food, and other industries. It is a component of the GURU.Markets index. The chart below represents the market. See how this company's stock compares to the industrial biotech sector.
Change in the price of a company, segment, and market as a whole per day
CDXS - Daily change in the company's share price Codexis Inc.
For Codexis, an enzyme development company, change_co is a measure of innovation volatility. Daily fluctuations reflect news about contracts with the pharmaceutical and food industries. This metric forms the basis for analyzing biotech platforms on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Dna
Codexis, Inc. is a biotech company. This chart highlights the sector's high volatility. Comparison with CDXS, with its enzyme production platform, helps us understand it as a key supplier to the pharmaceutical and food industries.
Daily change in the price of a broad market stock, index - GURU.Markets
Codexis is a biotechnology company developing enzymes for the pharmaceutical and food industries. Its business serves as a barometer of global scientific activity. The chart below shows general market fluctuations, which can be used to assess Codexis's stability.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Codexis Inc.
Codexis, Inc.'s year-over-year performance tells the story of its enzyme platform's application in pharmaceuticals. Its market capitalization over the past 12 months reflects both revenue from licensing its technologies to major pharmaceutical companies and progress in its own therapeutic programs, which underpins its long-term value creation strategy.
Annual dynamics of market capitalization of the market segment - Dna
Codexis, Inc. is a company that engineers enzymes used to create drugs and other products. Its unique technology platform is its key advantage. This chart shows how the market views its scientific potential, partnerships, and path to profitability.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Codexis, with its enzyme engineering platform, is a gold mine for biotech. Demand for its services is not dependent on the economy, but is driven by pharmaceutical companies' R&D budgets. The company's stock price reflects the long-term trend toward faster and cheaper drug development, making it a defensive technology bet.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Codexis Inc.
The performance of Codexis, an enzyme development company, is dependent on R&D cycles in the pharmaceutical industry. The monthly fluctuations on the chart reflect revenue from its partnerships with pharmaceutical companies that use its enzymes to produce drugs, as well as the success of its own therapeutic programs.
Monthly dynamics of market capitalization of the market segment - Dna
Codexis creates and supplies enzymes for the pharmaceutical and food industries using genetic engineering technologies. This biotech sector is the "shovel supplier" during the biopharma gold rush. The chart shows how the market valued companies whose technologies enable the faster and cheaper production of complex molecules.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Codexis is a protein engineering company. It creates enzymes for the pharmaceutical and food industries. Its stock price depends on success in developing new enzymes and establishing partnerships with major industrial players. It's a science-intensive company that lives by its own rules.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Codexis Inc.
Shares of Codexis, a company developing enzymes for the pharmaceutical and food industries, reflect activity in these sectors. Weekly price movements depend on news of partnerships with major manufacturers and research progress. The chart below shows how short-term scientific and commercial developments influence the company's valuation.
Weekly dynamics of market capitalization of the market segment - Dna
Is Codexis keeping pace with the biotech sector? The chart below compares the weekly performance of this enzyme development company's stock with the industry average. This helps assess whether its business is less volatile than that of drug developers, reflecting more stable demand for its technologies from pharmaceutical companies.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Codexis develops enzymes for use in pharmaceuticals and industrial applications. Its business is the "shovels and picks" of the biotech industry. This chart compares its weekly performance to the market to assess how its results are influenced by the overall level of funding and activity in the biotech industry.
Market capitalization of the company, segment and market as a whole
CDXS - Market capitalization of the company Codexis Inc.
Codexis, Inc.'s market capitalization is the valuation of its platform for "engineering" enzymes used to produce drugs and other products more efficiently. The company's value depends on the success of its partnerships with major pharmaceutical companies. The chart shows how investors value this unique biotechnology.
CDXS - Share of the company's market capitalization Codexis Inc. within the market segment - Dna
Codexis, Inc. is building market share by leveraging its enzyme engineering platform to improve pharmaceutical and food manufacturing processes and create new therapeutics.
Market capitalization of the market segment - Dna
Here's a chart of the total market capitalization of enzyme engineering companies. Codexis is a leader in this unique niche. The graph shows how the market values this pick-and-shovel technology, which helps pharmaceutical and food companies improve their production processes.
Market capitalization of all companies included in a broad market index - GURU.Markets
This chart visualizes the market value of enzymes as industrial workhorses. Codexis, Inc.'s market capitalization is a measure of its ability to create proteins for the production of drugs, food, and diagnostics. The line shows the importance of biotechnology, which makes chemistry greener and more efficient.
Book value capitalization of the company, segment and market as a whole
CDXS - Book value capitalization of the company Codexis Inc.
Codexis, Inc.'s book value represents its scientific capital. The chart below reflects the valuation of its enzyme engineering platform, which is used to produce drugs, food, and industrial products. The pipeline's growth signals progress in the development and commercialization of this unique technology.
CDXS - Share of the company's book capitalization Codexis Inc. within the market segment - Dna
Codexis's core assets are its laboratories and fermenters for "programming" enzymes used in pharmaceuticals and industrial applications. The chart shows the company's share of this unique bioengineering infrastructure, which serves as a "factory" for creating high-performance proteins.
Market segment balance sheet capitalization - Dna
Below you can see the overall book value of the biotech sector. Compared to this, Codexis, with its enzyme engineering platform, looks like a "lightweight." Its value lies in its unique technology, which it licenses, rather than in capital-intensive mass production.
Book value of all companies included in the broad market index - GURU.Markets
Codexis creates and produces enzymes (proteins) used to produce medicines, food, and industrial goods. The company's assets are laboratories and fermenters. The company's balance sheet is the value of a "biological factory" that creates unique "tools" for other sectors of the real economy.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Codexis Inc.
Codexis's balance sheet is its laboratories and fermenters. Its market valuation is determined by its belief in its enzyme design platform. When the MvsBCap_Co index is above one, it shows that investors value its ability to create unique biological "tools" more than the value of its tangible assets.
Market to book capitalization ratio in a market segment - Dna
Codexis is a biotech company that develops enzymes for the pharmaceutical and food industries. Its value lies in its scientific platform. The chart shows the market premium placed on its ability to "program" proteins to perform specific industrial tasks.
Market to book capitalization ratio for the market as a whole
Codexis is a protein engineering company that creates enzymes for use in the pharmaceutical and food industries. Its value lies in its scientific platform and ability to create new enzymes on demand. This chart illustrates why investors are willing to pay a premium for unique scientific platforms.
Debts of the company, segment and market as a whole
CDXS - Company debts Codexis Inc.
Codexis, a company developing enzymes for the pharmaceutical and food industries, uses debt to finance its scientific platform. This chart shows how the company raises capital for R&D and to expand the application of its technologies into new areas, such as gene editing. Debt here is an investment in biotech innovation.
Market segment debts - Dna
Codexis develops and produces enzymes used in the pharmaceutical and food industries to reduce costs and make production processes greener. This represents a unique niche in biotechnology. This chart shows how the company funds its research and development, creating customized solutions for its industrial clients.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Codexis Inc.
Codexis develops and markets enzymes for the pharmaceutical and food industries. This chart shows its financial structure. For a biotech company operating in the B2B sector, a stable balance sheet is essential. Debt levels may reflect investments in new R&D platforms, which are a bet on future partnerships and licensing agreements.
Market segment debt to market segment book capitalization - Dna
Codexis is a biotech company developing enzymes for pharmaceutical and industrial applications. It is an innovative platform with broad applicability. The chart shows how the company's debt load for R&D funding compares to the overall market capitalization of the biotech sector.
Debt to book value of all companies in the market
Codexis (CDXS) is a company that engineers enzymes for the pharmaceutical and food industries. Its technologies make production processes more efficient. This chart shows the overall debt load of the economy. It allows one to evaluate the financial model of a company whose business is based on intellectual property rather than heavy assets.
P/E of the company, segment and market as a whole
P/E - Codexis Inc.
This chart for Codexis, Inc., a company that "programs" enzymes for use in pharmaceuticals and industrial applications, is a measure of faith in its unique platform. Its P/E ratio depends on the success of its partnerships with major companies. Its growth suggests that its technology is finding wider application.
P/E of the market segment - Dna
This industry metric represents the average P/E for biotech companies. For Codexis, with its enzyme programming platform, it's an important benchmark. It helps understand how investors value its unique business model, based on partnerships and licensing, compared to traditional pharma companies.
P/E of the market as a whole
Codexis is a biotech company that develops enzymes for use in the pharmaceutical, food, and industrial sectors. The company's technology makes chemical processes more efficient and environmentally friendly. This chart, reflecting overall sentiment, helps understand how investors view companies creating innovative solutions for industry.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Codexis Inc.
Codexis is a biotechnology company that develops and markets enzymes for use in the pharmaceutical and food industries. These enzymes make production processes more efficient and environmentally friendly. This graph reflects expectations for the growth of "green chemistry." The estimate depends on demand for its enzymes and new partnerships.
%20P%2FE%20Codexis%20Inc.&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Codexis-Inc.&v=1772513407694 "Chart of the company's future (projected) P/E Codexis Inc.")
Future (projected) P/E of the market segment - Dna
Codexis develops and markets enzymes for use in the pharmaceutical and food industries. This chart compares the company's future profitability expectations with the industry average. It reflects the market's confidence in their ability to create new, more effective enzymes that will be in demand by industry.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Dna&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Dna&v=1772513407702 "Future (projected) P/E graph of the market segment - Dna")
Future (projected) P/E of the market as a whole
Codexis is a biotechnology company that engineers enzymes for use in pharmaceuticals and industrial applications. Its technology makes chemical processes more efficient. This market outlook influences Codexis through its clients' R&D budgets. Economic growth stimulates investment in innovation, which benefits the company.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772513407719 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Codexis Inc.
Codexis is a biotechnology company that develops enzymes for use in the pharmaceutical and food industries. These enzymes make production processes more efficient and environmentally friendly. The company's revenue depends on licensing agreements and partnerships with major industrial companies.
Profit of companies in the market segment - Dna
Codexis develops and produces enzymes used in the pharmaceutical and food industries to reduce costs and make production greener. This technology is key to "green chemistry." This graph illustrates how industrial biotechnology is creating new opportunities for efficiency gains and impacting overall profitability in traditional industries.
Overall market profit
Codexis is a biotechnology company that develops enzymes for the pharmaceutical and food industries. Its technologies help make production processes more efficient and environmentally friendly. Demand for such innovations is driven by the drive for optimization, which is relevant at any stage of the economic cycle, as shown in this chart.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Codexis Inc.
Codexis is a protein engineering company that creates enzymes for use in pharmaceuticals, food, and diagnostics. This chart shows revenue expectations, which depend on the success of its partnerships with major companies and royalties received from products created using its technology.
%20profit%20of%20the%20company%20Codexis%20Inc.&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Codexis-Inc.&v=1772513407744 "Graph of future (projected) profit of the company Codexis Inc.")
Future (predicted) profit of companies in the market segment - Dna
Codexis is a biotechnology company that develops enzymes for use in the pharmaceutical and food industries. This chart shows the revenue forecast for the entire DNA technology and enzymology industry. It reflects expectations for the adoption of green chemistry and new drug production methods. This trend is driving Codexis's partnership programs.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Dna&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Dna&v=1772513407761 "Graph of future (predicted) profits of companies in a market segment - Dna")
Future (predicted) profit of the market as a whole
Codexis creates and supplies enzymes for the pharmaceutical and food industries. Its technology makes production processes more efficient and "green." Demand for its products depends on the R&D budgets of its clients. The growth forecasts shown in this chart indicate the companies' willingness to invest in innovation and production optimization.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772513407769 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Codexis Inc.
Codexis is a biotech company that develops enzymes for use in the pharmaceutical, food, and other industries. Its enzymes make production processes more efficient and environmentally friendly. This chart shows how investors value its unique technology platform and its partnerships with major industrial companies.
P/S market segment - Dna
Codexis is an enzyme development company that uses its technology platform to create unique proteins that accelerate chemical reactions. These enzymes are used in drug and food production, as well as diagnostics. This chart shows the average valuation in the sector, helping to understand how the market values this innovative scientific platform.
P/S of the market as a whole
Codexis is a biotechnology company that develops and sells enzymes for the pharmaceutical and food industries. The company's enzymes are used to reduce costs and make production processes greener. This market valuation chart allows you to compare how investors value the revenue of a company providing technologies to other industries.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Codexis Inc.
Codexis develops enzymes for use in the pharmaceutical and food industries. Future revenue depends on licensing agreements and royalties from products created using its technology. This chart shows how the market values its platform and its future contribution to new product development.
%20P%2FS%20Codexis%20Inc.&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Codexis-Inc.&v=1772513407803 "The graph of the company's future (projected) P/S Codexis Inc.")
Future (projected) P/S of the market segment - Dna
Codexis is a protein engineering company that creates enzymes for use in the pharmaceutical and food industries. This chart compares market expectations for its future revenue with other companies in the DNA technology sector. The valuation reflects investor confidence in its unique technology platform.
%20P%2FS%20market%20segment%20graph%20-%20Dna&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Dna&v=1772513407819 "Future (projected) P/S market segment graph - Dna")
Future (projected) P/S of the market as a whole
Codexis develops enzymes used to reduce costs and improve production efficiency in the pharmaceutical and food industries. It is a provider of technologies for innovation. Market optimism, as seen in this chart, indicates increased investment in R&D. This directly increases demand for Codexis solutions from companies seeking innovation.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772513407830 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Codexis Inc.
Codexis is a company that engineers enzymes used as catalysts in the pharmaceutical and food industries. The company's revenue comes from sales of these enzymes and licensing fees for its technology. The graph shows revenue from its innovative protein engineering, which makes industrial processes more efficient.
Sales of companies in the market segment - Dna
Codexis is a biotechnology company that develops and produces enzymes for the pharmaceutical and food industries. Its "directed evolution" technology enables the creation of enzymes with specific properties to optimize chemical processes. Revenue is generated from product sales and licensing. This graph shows the growing demand for biotech solutions in industry.
Overall market sales
Codexis develops enzymes for use in the pharmaceutical and food industries. Demand for its products depends on R&D activity in these sectors. This trend, reflecting overall business confidence, influences companies' willingness to invest in the development of new products and processes that can utilize Codexis enzymes.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Codexis Inc.
Codexis is a biotechnology company that develops and produces enzymes for use in the pharmaceutical and food industries. These enzymes accelerate chemical reactions, making production more efficient and environmentally friendly. This chart shows analysts' expectations for the adoption of enzyme technologies in industry.
%20sales%20of%20the%20company%20Codexis%20Inc.&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Codexis-Inc.&v=1772513407904 "Schedule of future (projected) sales of the company Codexis Inc.")
Future (projected) sales of companies in the market segment - Dna
Codexis is a protein engineering company that creates enzymes for use in pharmaceuticals, food, and other industries. This chart shows the outlook for the DNA and protein research sector, demonstrating how the company's unique technology platform enables it to create new solutions for a wide range of industrial processes.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Dna&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Dna&v=1772513407963 "Schedule of future (projected) sales of companies in the market segment - Dna")
Future (projected) sales of the market as a whole
Codexis, Inc. develops enzymes for use in the pharmaceutical and food industries. This chart, reflecting R&D investments in these sectors, is important to the company. The drive to create more efficient and environmentally friendly production processes is driving demand for the specialized enzymes Codexis offers.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772513407970 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Codexis Inc.
Codexis is an enzyme engineering company. It creates unique proteins that make chemical processes in pharmaceuticals, food, and other industries more efficient and environmentally friendly. This chart shows how the company monetizes its cutting-edge scientific platform through partnerships and licensing.
Market segment marginality - Dna
Codexis, Inc. is a protein engineering company. They create enzymes used to produce medicines, food, and other industrial products more efficiently and greener. This chart shows how their unique scientific platform and partnerships with major companies translate into operational profitability.
Market marginality as a whole
Codexis is a protein engineering company. They create enzymes that make pharmaceutical and food production processes more efficient and environmentally friendly. Their overall profitability is driven by science and innovation. Their high profitability is based on the unique technology they license to clients.
Employees in the company, segment and market as a whole
Number of employees in the company Codexis Inc.
Codexis is a protein engineering company that creates enzymes for the pharmaceutical and food industries. This graph shows a team of scientists working at the forefront of biotechnology. The growth of the team reflects the expansion of partnerships and the application of its platform to new areas.
Share of the company's employees Codexis Inc. within the market segment - Dna
Codexis is a protein engineering company that creates enzymes for use in pharmaceuticals, food, and other industries. This chart shows the percentage of leading scientists in this niche biotech field that the company attracts. This is a testament to its unique technology platform and team creating "green" catalysts.
Number of employees in the market segment - Dna
Codexis, Inc. is a biotechnology company that develops enzymes for use in pharmaceuticals, food, and other industries. This chart shows employment in the industrial biotechnology sector. The growing number of scientists reflects the company's ability to create new, more efficient enzymes that make production processes more environmentally friendly and cost-effective.
Number of employees in the market as a whole
Codexis, Inc. is a protein engineering company. It creates enzymes used to produce drugs, food, and industrial chemicals more efficiently and sustainably. This graph illustrates overall employment, and innovative companies like Codexis exemplify how biotechnology is disrupting traditional industries and creating new jobs.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Codexis Inc. (CDXS)
Codexis, Inc. develops enzymes for the pharmaceutical and food industries. It's a science-intensive business whose main asset is their protein engineering technology platform. This chart demonstrates a very high market capitalization per employee. A small team of scientists can create an enzyme that optimizes production for millions of dollars for their clients.
%20of%20the%20company%20Codexis%20Inc.%20(CDXS)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Codexis-Inc.-CDXS&v=1772513408179 "Chart of market capitalization per employee (in thousands of dollars) of the company Codexis Inc. (CDXS)")
Market capitalization per employee (in thousands of dollars) in the market segment - Dna
Codexis is a protein engineering company. It creates enzymes used to produce drugs, food, and industrial chemicals more efficiently and sustainably. The chart shows the market premium for its unique scientific platform. The cost per employee reflects the value of its intellectual capital.
%20by%20market%20segment%20-%20Dna&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Dna&v=1772513408183 "Market capitalization per employee (in thousands of dollars) by market segment - Dna")
Market capitalization per employee (in thousands of dollars) for the overall market
Codexis is a protein engineering company. They create enzymes used to produce medicines, food, and other industrial products more efficiently and sustainably. This chart highlights the value of their unique scientific platform, which has applications across many industries.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772513408186 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Codexis Inc. (CDXS)
Codexis (CDXS) is a biotech company that designs enzymes for use in pharmaceuticals and industrial applications. This is called "protein engineering." This chart shows how successfully they monetize their unique R&D platform, generating revenue per scientist.
%20Chart%20Codexis%20Inc.%20(CDXS)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Codexis-Inc.-CDXS&v=1772513408196 "Company Profit Per Employee (in thousands of dollars) Chart Codexis Inc. (CDXS)")
Profit per employee (in thousands of dollars) in the market segment - Dna
Codexis is an enzyme engineering company. They create modified enzymes that make chemical processes (for example, in pharmaceuticals) more efficient. This chart shows the benchmark for biotech staff efficiency. It's important for assessing how successfully Codexis is monetizing its unique R&D platform.
%20in%20the%20market%20segment%20-%20Dna&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Dna&v=1772513408207 "Chart of profit per employee (in thousands of dollars) in the market segment - Dna")
Profit per employee (in thousands of dollars) for the market as a whole
Codexis (CDXS) is an enzyme engineering company. They use AI and biotechnology to create custom enzymes used in the production of drugs, food, and other products. They are a B2B platform. This chart shows how successful their R&D team is in creating in-demand enzymes, generating revenue from royalties and licensing.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772513408214 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Codexis Inc. (CDXS)
Codexis is a biotech company that develops enzymes for the pharmaceutical and food industries. This chart demonstrates the effectiveness of its B2B model. The growth in revenue per employee reflects the company's ability to partner with large manufacturers who use its enzymes to reduce costs and improve their production processes.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Codexis-Inc.-CDXS&v=1772513408227 "Sales chart per company employee Codexis Inc. (CDXS)")
Sales per employee in the market segment - Dna
Codexis (CDXS) is a biotech company specializing in enzyme engineering. They create custom enzymes for pharmaceutical companies (for drug production) and other industries. This chart shows how much revenue (from products and R&D) each employee (scientist) generates. This is an indicator of the value of their science-intensive platform.
Sales per employee for the market as a whole
Codexis (CDXS) is an enzyme engineering company. They use AI to create customized enzymes that make drug production more efficient. They operate an R&D platform. This chart shows how their research team generates revenue by licensing these enzymes or receiving R&D fees from major pharmaceutical and industrial companies.
Short shares by company, segment and market as a whole
Shares shorted by company Codexis Inc. (CDXS)
Codexis, Inc. is a company that develops engineered enzymes for use in pharmaceuticals and industrial applications. This chart shows bearish bets. The shorts may be driven by the company's loss of key partners (such as Pfizer), which casts doubt on future royalty revenues and calls into question its business model.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Codexis-Inc.-CDXS&v=1772513408253 "Short Shares Chart for the Company Codexis Inc. (CDXS)")
Shares shorted by market segment - Dna
Codexis (CDXS) is a company that develops specialized enzymes for use in pharmaceuticals and industrial applications (such as food production). This chart shows bets against the biotech sector. The rising bets against the industry reflect concerns that R&D budgets of pharmaceutical companies (CDXS clients) will be cut due to the recession.
Shares shorted by the overall market
Codexis engineers enzymes for pharmaceuticals and biosciences. It's a highly specialized B2B company. While its clients are in defensive sectors, Codexis itself is a fast-growing technology company. High market fear (as shown in this chart) tends to punish growth stocks, even such specialized ones.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Codexis Inc. (CDXS)
Codexis develops enzymes for the pharmaceutical and food industries. Its business depends on its clients' R&D budgets. A chart above 70 may reflect strong demand or new partnerships. A level below 30 is often associated with concerns about R&D budget cuts (a "venture winter") or contract losses.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Codexis-Inc.-CDXS&v=1772513408319 "RSI 14 indicator chart for the company's stock Codexis Inc. (CDXS)")
RSI 14 Market Segment - Dna
Codexis (CDXS) is a protein engineering company. It uses its platform to create unique enzymes used by pharmaceutical companies to produce drugs. It's a "tool" for R&D. This chart measures the collective momentum of the biotech hardware sector. It shows whether the entire biotech sector is overheated or whether CDXS has its own drivers.
RSI 14 for the overall market
Codexis (CDXS) is a biotech platform. This chart is an indicator of R&D health. In the midst of euphoria, biotechs (CDXS clients) are generously funded and launch hundreds of clinical trials using its platform. In the midst of panic, R&D funding freezes, the number of trials drops, and demand for CDXS services declines.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast CDXS (Codexis Inc.)
Codexis is a biotech company (an enzyme engineering company). It uses its CodeEvolver platform to create customized enzymes used in the production of medicines and food products. This chart shows the average analyst price target based on its R&D contracts.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-CDXS-Codexis-Inc.&v=1772513408382 "A chart showing analyst consensus forecasts for the expected stock price. CDXS (Codexis Inc.)")
The difference between the consensus estimate and the actual stock price CDXS (Codexis Inc.)
Codexis (CDXS) is a biotech company that uses AI and machine learning to design unique enzymes. These enzymes are used by pharmaceutical companies to reduce costs and speed up drug production. This chart shows the difference between the consensus forecast and the price, reflecting analysts' confidence in this R&D platform.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-CDXS-Codexis-Inc.&v=1772513408430 "A chart showing the difference between the consensus forecast and the actual stock price. CDXS (Codexis Inc.)")
Analyst consensus forecast for stock prices by market segment - Dna
Codexis is a "programmer" for biology. The company uses AI to "design" enzymes that help pharmaceutical companies produce drugs more efficiently and sustainably. This chart shows general expectations for the DNA technology sector. It reflects whether experts believe in the growth of the biomanufacturing market in the pharmaceutical and food industries.
Analysts' consensus forecast for the overall market share price
Codexis is a "supplier" of "shovels" for "pharma." They "design" "enzymes" that "accelerate" R&D and "production" of "drugs." This chart of overall market sentiment is important. "Optimism" = "biotechs" "easily" "attract" "money" and "spend" it on "R&D" (by purchasing CDXS's "services"). "Pessimism" = "venture" "winter" = "R&D" "freeze."
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Codexis Inc.
Codexis (CDXS) is a design company. Their specialty is enzyme engineering. They use AI to create custom enzymes (proteins) that make chemical processes (in pharma and food) faster and cleaner. This chart represents their R&D bet. It weighs their service business (R&D for giants) against their own, riskier, therapeutic pipeline.
AKIMA Market Segment Index - Dna
Codexis is an enzyme design company. It uses its AI platform to create proteins that make chemical processes (in pharmaceuticals and food) more efficient. This chart shows the average index for the DNA technologies segment. It allows you to assess how Codexis's innovative platform performs compared to the sector average.
The AKIM Index for the overall market
Codexis is a leader in enzyme engineering, creating biocatalysts for pharmaceuticals, food, and life sciences. This chart, reflecting the market average, is a backdrop. It helps assess how this synthetic biology platform, undergoing restructuring, compares to overall macroeconomic trends.
